DNA methylation changes and multiple myeloma

Leukemia and Lymphoma

Volumn 34, Issue 5-6, 1999, Pages 463-472

  Ng, M H L ^a   Wong, I H N ^a   Lo, K W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

MM; p16 p15 hypermethylation; Transcriptional silencing

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; PROTEIN P15; PROTEIN P16; TUMOR MARKER;

CARCINOGENESIS; CELL GROWTH; CELL LINE; CHROMOSOME; CODING; CPG ISLAND; DNA METHYLATION; GENETIC TRANSCRIPTION; HUMAN; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SOLID TUMOR;

EID: 0032846413     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058473     Document Type: Review

References (62)

1. Joshua, D. E., Brown, R. D. and Gibson, J. (1994) Prognostic factors in myeloma: What they tell us about the pathophysiology of the disease. Leukemia and Lymphoma, 15, 375-381.
2. Zandecki, M. (1996) Multiple myeloma: almost all patients are cytogentically abnormal. Br. J. Haematol., 94, 217-227.
3. Feinman, R., Sawyer, J., Hardin, J and Tricot, G. (1997) Cytogenetics and molecular genetics in multiple myeloma. Hematol. Oncol. Clin. N. Am., 11, 1-25.
4. Bergsagel, P.L., Chesi, M., Nardini, E., Brents, L.A., Kirby, S.L. and Kuehl, W.M. (1996) Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc. Natl. Acad. Sci. USA, 93, 13931-13936.
5. Bergsagel, P.L., Nardini, E., Brents, L., Chesi, M. and Kuehl, W.M. (1997) IgH translocations in multiple myeloma: a nearly unversal event that rarely involves c-myc. Curr. Topics Microbiol. Immunol., 224, 283-287.
6. Rao, P. H., Cigudosa, J. C., Ning, Y., Calasanz, M. J., Iida, S., Tagawa, S., Michaeli, J., Klein, B., Dalla-Favera, R., Jhanwar, S. C., Ried, T. and Chaganti, R. S. K. (1998) Multicolor spectral karyotyping identifies new recurring breakpoints and translocations inmultiple myeloma. Blood, 92, 1743-1748.
7. Hallek, M., Bergsagel, P. L. and Anderson, K. C. (1998). Multiple Myeloma: Increasing evidence for a multistep transformation process. Blood, 91, 3-21.
8. Ng, M. H. L., Kan, A., Chung, Y. F., Wong, I. H. N., Lo, K. W., Lie, K. I. K., Wickham, N. W. R. and Lee, J. C. K. (1999) Combined morphological and interphase fluorescence in-situ hybridization study in multiple myeloma of Chinese patients. Am. J. Pathol., 154, 15-22.
9. Corradini, P., Inghirami, G., Astolfi, M., Ladetto, M., Voena, C., Ballerini, P., Gu, W., Nilsson, K., Knowles, D. M., Boccadoro, M., Pileri, A. and Dalla-Favera, R. (1994) Inactivation of tumor suppressor genes, p53 and Rb1 in plasma cell dyscrasias. Leukemia, 8, 758-767.
10. Dao, D. D., Sawyer, J. R., Epstein, J. R., Hoover, G., Barlogie, B. and Tricot, G. (1994) Deletion of the retinoblastoma gene in multiple myeloma. Leukemia, 8, 1280-1284.
11. Juge-Morineau, N., Mellerin, M. P., Francois, S., Rapp, M. J., Harousseau, J. L., Amiot, M. and Bataille, R. (1995). High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells. Br. J. Haematol., 91, 664-667.
12. Hirama, T. and Koeffler, H. P. (1995). Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86, 841-854.
13. Santhanam, U., Ray, A. and Sehgal, P. B. (1991) Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Nail. Acad. Sci. USA, 88, 7605-7609.
14. Lichtenstein, A., Tu, Y., Fady, C., Vescio, R. and Berenson, J. (1995) Interleukin-6 inhibits apoptosis of malignant plasma cells. Cell Immunol., 162, 248-254.
15. Karp, J. E. and Broder, S. (1995) Molecular foundations of cancer: New targets for intervention. Nature Medicine, 1, 309-319.
16. Serrano, M., Hannon, G. J. and D. Beach. (1993) A new regulation motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707.
17. Kato, J. Y., Matsushime, H. S., Hiebert, W. M., Ewen, E. and Sherr, C. J. (1993). Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7, 331-342.
18. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J. and Livingston, D. M. (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73, 487-497.
19. Weinberg, R. A. (1995). The retinoblastoma gene and cell cycle control. Cell, 81: 381-392.
20. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. and Carson, D. A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756.
21. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stocken, E., Day III, R. S., Johnson, B. E. and Skolnick, M. H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
22. Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W. and Vogelstein, B. (1994) Deletion of p16 and p15 gene in brain tumors. Cancer Res., 54, 6353-6358.
23. Herman, J. G., Merlo, A., Mao, L., Lapiduc, R. G., Issa, J. P. J., Davidson, N. E., Sidransky, D. and Baylin, S. B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.
24. INK4B1. Cancer Res., 56, 722-727.
25. Lo, K. W., Huang, D. P. and Lau, K. M. (1995) p16 gene alterations in naopharyngeal carcinoma. Cancer Res., 55, 2039-2045.
26. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-261.
27. Hooper WC. (1991) The role of transforming growth factor-β in hematopoiesis. A review. Leuk Res., 15, 179-184.
28. Quesnel, B., Preudhomme, C. N., Philippe, K., Vanrumbeke, I. Dervite, J., Lai, L., Bauters, F., Wattel, E. and Fenaux, P. (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85, 657-663.
29. Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., Shimazaki, C., Toyama, K., Hirano, M., Mizoguchi, H., Kobayashi, Y., Furusawa, S., Saito, M., Emi, N., Yazaki, Y., Ueda, R. and Hirai, H. (1995) Loss of the cyclin-dependent kinase 4-inhibitor (p16;MTS1) gene is frequent in and highly specific to lymphoid tumours in primary human hematopoietic malignancies. Blood, 86, 1548-1556.
30. 15INK4B, p53, and Rb genes in primary lymphoiud nalignancies. Blood, 87, 4949-4958.
31. Tasaka, T., Berenson, J., Vescio, R., Hirama, T., Miller, C. W., Nagai, M., Takahara, J. and Koellfer, H. P. (1997) Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma. Br. J. Haematol, 96, 98-101.
32. Stranks, G., Height, S. E., Mitchell, P., Jadayel, D., Yuille, M. A. R., DeLord, C., Clutterbuck, R. D., Treleaven, J. G., Powles, R. L., Nacheva, E., Oscier, D. G., Karpas, A., Lenoir, G. M., Smith, S. D., Millar, J. L., Catovsky, D. and Dyer, M. J. S. (1995) Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood, 85, 893-901.
33. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B. and Sidransky, D. (1995) 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692.
34. Issa, J. P. J., Baylin, S. B. and Herman, J.G. (1997) DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia, 11, S7-S11.
35. Jones, P. A. and Gonzalgo M. L. (1997) Altered DNA methylation and genomic instability: A new pathway to cancer? Proc. Natl. Acad. Sci. USA, 94, 2103-2105.
36. Leonhardt, H. and Bestor, T.H. (1993) Structure, function, and regulation of mammalian DNA methytransferase. EXS., 64, 109-119.
37. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M. and Issa, J. P. (1998) Alterations in DNA methylation: A fundamental Aspect of Neoplasia. Adv. Cancer Res., 72, 141-196.
38. Narayan, A., Ji. W., Zhang, X. Y., Marrogi, A., Graff, J. R., Baylin, S. B. and Ehrilich, M. (1998) Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int. J. Cancer, 77, 833-838.
39. Lengauer, C, Kinzler, K. W. and Vogelstein, B. (1997) DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl. Acad. Sci. USA, 94, 2545-2550.
40. Zandecki, M., La, J-L, Genevieve, F., Bernardi, F., Volle-Remy, H., Blanchet, O., Francois, M., Cosson, A., Bauters, F. and Facon, T. (1997) Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. Blood, 90, 3682-3690.
41. Lengauer, C., Kinzler, K. W. and Vogelstein, B. (1997) Genetic instability in colorectal cancers. Nature, 386, 623-627.
42. Pihan, G. A., Purohit, A., Wallace, J., Knecht, H., Woda, B., Quesenberry, P. and Doxsey, S. J. (1998) Centrosome defects and genetic instability in malignant tumors. Cancer Res., 58, 3974-3985.
43. Sawyer, J. R., Tricot, G., Mattox, S., Jagannath, S. and Barlogie, B. (1998) Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood, 91, 1732-1741.
44. Kautiainen, T. L. and Jones, P. A. (1986) DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J. Biol. Chem., 261, 1594-1598.
45. Issa, J. P., Vertino, P. M., Wu, J., Sazawal, S., Celano, P., Nelkin, B. D., Hamiltor, S. R. and Baylin, S. B. (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression. J. Natl. Cancer. Inst., 85, 1235-1240.
46. Belinsky, S. A., Nikula, K. J., Baylin, S. B. and Issa, J. P. J. (1996) Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA, 93, 4045-4050.
47. MacLeod, A. R. and Szyf, M. (1995) Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J. Biol. Chem., 270, 8037-8043.
48. Jones, P. A. (1996). DNA methylation errors and cancer. Cancer Res., 56, 2463-2467.
49. WAF1. Science, 277, 1996-2000.
50. Waga, S., Hannon, G. J., Beach, D. and Stillman, B. (1994) The p21 inhibition of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 369, 574-578.
51. Robertson, K. D. and Jones, P. A. (1997) Dynamic interrelatioship between DNA replication, methylation, and repair. Am. J. Hum. Genet., 61, 1220-1224.
52. Chung, Y. F., Ng, M. H. L., Lo, K. W., Wong, I. H. N., Wickham, N. W. R., Huang, D. P. and Lee, J. C. K. (1998) Genetic alterations of Rb and p16/p15 in multiple myeloma. Cancer Detection and Prevention, 22(Sppl), S-171.
53. Ng, M. H. L., Chung, Y. F., Lo, K. W., Wickham, N. W. R., Lee, J. C. K. and Huang, D. P. (1997) Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood, 89, 2500-2506.
54. Wong, I. H. N., Ng, M. H. L., Lee, J. C. K., Lo, K. W., Chung, Y. F. and Huang, D. P. (1998) Transcriptional silencing of the p16 gene by hypermethylation in human myeloma-derived cell lines. Br. J. Haematol., 103, 168-175.
55. INK4A gene in multiple myeloma. Br. J. Haematol., 101, 558-564.
56. Urashima, M., Teog, G., Ogata, A., Chauhan, D., Treon, S. P., Sugimoto, Y., Kaihara, C, Matsuzaki, M., Hoshi, Y., DeCaprio, J. A. and Anderson, K. C. (1997) Characterization of p16 INK4A expression in multiple myeloma and plasma cell leukemia, Clin. Cancer Res., 3, 2173-2179.
57. Gonzalgo, M. L., Bender, C. M., You, E. H., Glendening, M., Flores, J. F., Walker, G. J., Hayward, N. K., Jones, P. A. and Fountain, J. W. (1997) Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Res., 57, 5336-5347.
58. Otterson, G. A., Kratzke, R. A., Coxon, A., Kim, Y. W. and Kaye, F. J. (1994) Absence of p16ink4 protein is restricted to the subset of lung cancer lines that retains wild type Rb. Oncogene, 9, 3375-3381.
59. Okamoto, A. E. (1994) Mutations and altered expression of genes regulating the cell cycle G1 checkpoint in human cancer. Proc. Natl. Acad. Sci. USA, 91, 11045-11049.
60. Yeager, T., Stadler, W., Belair, C., Puthenveettil, J., Olopade, O. I. and Reznikoff, C. (1995) Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res., 55, 493-497.
61. Parry, D., Bates, S., Mann, D. J. and Peters, G. (1995) Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4A/MTS1 tumor suppressor gene product. EMBO J., 14, 503-510.
62. Wong, I. H. N., Ng, M. H. L., Lei, K. I. K., Yuen, P. M. P. and Huang, D. P. (1998) Aberrant p15 methylation as molecular marker and prognostic factor in acute leukemia. Blood, 92 (sppl 1), 228a.